The largest database of trusted experimental protocols

Puregene dna purification kit

Manufactured by Qiagen
Sourced in United States, Germany

The Puregene DNA purification kit is a laboratory product designed for the extraction and purification of DNA from a variety of sample types. The kit utilizes a simple and efficient protocol to isolate high-quality genomic DNA that can be used in downstream applications such as PCR, sequencing, and genotyping.

Automatically generated - may contain errors

90 protocols using puregene dna purification kit

1

Quantitative PCR for Vector DNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Vector and 2-LTR circular DNA was detected using quantitative PCR assay based on a method previously described by Butler et al55 (link). Total cellular DNA was prepared using a Puregene DNA Purification Kit (Gentra Systems, Inc., Minneapolis, MN), from which a 250 ng or 500 ng sample was used for each reaction. To determine total, integrated, and 2-LTR circular vector DNA copy number, standard curves were generated by preparing serial dilutions of pcDNA-CS-CGW, genomic DNA from wild-type vector transduced HEK293 cells, or a 2-LTR circle reference plasmid that was generated upon the introduction of a 2-LTR fragment into a cloning vector, pCR4-TOPO (Invitrogen, Carlsbad, CA), respectively. Each sample was run in duplicate and data analysis was performed using Sequence Detection Systems 1.9.1 software (Applied Biosystems, Foster City, CA).
A 250 ng sample of total cellular DNA from transduced HEK293 cells at 3 days post-transduction was used for detection of 1-LTR circular vector DNA by standard PCR. 1-LTR circles were amplified using the following primers: 5’-GACCAATGACTTACAAGGCAGC-3’ (forward) and 5’-GCAAGCCGAGTCCTGCGTCG-3’ (reverse). The cycling conditions were 95°C for 10 min, thirty cycles of 92°C for 1 min, 56°C for 2 min, 72°C for 1.5 min, and 72°C for 7 min.
+ Open protocol
+ Expand
2

Chromosomal and Plasmid DNA Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chromosomal DNA was extracted from B. cereus cells with the Puregene DNA Purification kit (Gentra Systems, USA). Plasmid DNA was extracted from E. coli using QIAprep spin columns (QIAGEN, France). Restriction enzymes (New England Biolabs, USA) and T4 DNA ligase (New England Biolabs, USA) were used in accordance with manufacturer’s recommendations. Oligonucleotide primers were synthesized by Sigma-Proligo (Paris, France). PCR was performed in an Applied Biosystem 2720 Thermal cycler (Applied Biosystem, USA). Amplified fragments were purified with the QIAquick PCR Purification Kit (QIAGEN, France). Digested DNA fragments were extracted from gels with the QIAquick Gel Extraction Kit (QIAGEN, France). Nucleotide sequences were determined by Cogenics (Meylan, France).
+ Open protocol
+ Expand
3

Idiopathic ASD Cohort from Spain

Check if the same lab product or an alternative is used in the 5 most similar protocols
We studied 36 unrelated males with a diagnosis of idiopathic ASD selected from a Spanish cohort of 324 patients. All cases except two were sporadic. All patients had a confirmed diagnosis of one of the categories of ASD listed in the Diagnosis and Statistical Manual of Mental Diseases IV (DSM-IV), categorized according to the Spanish version of ADI-R (Autism Diagnostic Interview-Revised), and the Wechsler Intelligence Scale for Children or Wechsler Adult Intelligence Scale. All patients had an extensive clinical and molecular evaluation including fragile X testing and molecular karyotype (either BAC, oligo, or SNP array) with normal results. The study was approved by the Clinical Research Ethics Committee of the centers involved (CEIC-Parc Salut Mar), and informed consent for participation was obtained from the parents or legal caregivers. Blood samples were obtained, and genomic DNA was extracted by the salting out method using the Puregene® DNA Purification Kit (Gentra Systems, Big Lake, MN, USA). Parental and familial samples were obtained from the available relatives who gave informed consent.
+ Open protocol
+ Expand
4

Genotyping of CYB5R3 rs1800457

Check if the same lab product or an alternative is used in the 5 most similar protocols
gDNA was isolated from whole heart tissue using the PureLink Genomic DNA Mini Kit (Invitrogen, K1820-01). gDNA was quantified via NanoDrop (Thermo Fisher). For participants in the GRACE and GRAHF studies, DNA was isolated from peripheral blood by leukocyte centrifugation and cell lysis using the PureGene DNA Purification Kit (Gentra Systems). DNA (2 ng) was loaded into a 384-well plate with TaqMan Genotyping Master Mix (Thermo, 4371353) and CYB5R3 rs1800457 SNP Genotyping Assay (Thermo, 2986292_20). Analysis distinguished genotypes based on VIC/FAM fluorescence amplification (Thermo Fisher).
+ Open protocol
+ Expand
5

DNA extraction and gene amplification for biodiversity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA was extracted from 96% ethanol-preserved tissue samples (liver, muscle tissue or scales) using a modified salt precipitation method based on the Puregene DNA purification kit (Gentra Systems). We amplified the 16S gene using the primers 16Sar-L and 16Sbr-H-R from Palumbi et al. (1991) . Additionally, the Cytb gene was obtained with the primers L14910 and H16064 developed by Burbrink et al. (2000) (link), whereas the gene coding for the subunit 4 of the NADH dehydrogenase was amplified with the primers ND4 and Leu developed by Arévalo et al. (1994) . PCR reactions contained 2 mM (Cytb and ND4) or 3 mM (16S) MgCl2, 200 µM dNTP mix, 0.2 µM (16S and Cytb) or 0.8 µM (ND4) of each primer and 1.25 U (16S and Cytb) or 0.625 U (ND4) Taq DNA Polymerase Recombinant (Thermo Fisher Scientific) in a 25 µL total volume. The nucleotide sequences of the primers and the PCR conditions applied to each primer pair are detailed in Appendix II. PCR products were cleaned with Exonuclase I and Alkaline Phosphatase (Illustra ExoProStar by GE Healthcare) before they were sent to Macrogen Inc (Korea) for sequencing. All PCR products were sequenced in both forward and reverse directions with the same primers that were used for amplification. The edited sequences were deposited in GenBank (Appendix I).
+ Open protocol
+ Expand
6

Jordanian Family Genetic Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols
The index cases of the Jordanian family were initially diagnosed at the National Center for Diabetes, Endocrinology & Genetics in Jordan by Prof. Hanan Hamamy. Clinical assessments were undertaken at different clinics at the University hospital of Jordan. Saliva samples were collected from the whole family members (I.1, I.2, and II.1 to II.6) and skin biopsies were obtained from Family 1 (individuals I.2 and II.4). Family 2 was diagnosed at the Imagine Institute in France by Prof. Jeanne Amiel. Blood and skin biopsy were collected from age-matched health individuals and patient II.4 from Family 2. Genomic DNA was extracted (Puregene DNA Purification Kit, GentraSystems) following manufacturer’s instructions. Nasal epithelial cells were also obtained (Family 1: I.2, II.4 and II.5) by nasal-brush biopsy (Cytopbrush Plus, Medscand, Sweden). These investigations were conducted following ethical approval by the local IRBs in France and Singapore (A*STAR, 2019-087). Patients and their families have given informed consent for publication of photographs.
+ Open protocol
+ Expand
7

HLA Typing of Cord Blood Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA was extracted from anticoagulated CB using a Puregene DNA purification kit (Gentra Systems, Minneapolis, MN, USA). Each sample was typed for the HLA-A, -B, and -DRB1 alleles at low-to-intermediate resolution by the polymerase chain reaction with sequence-specific oligonucleotide probe typing method using Dynal Reli SSO typing kits (Invitrogen, Bromborough, UK) according to the manufacturer’s protocols16 (link). Based on the consensus of the Korean marrow donor program, 2-digit level DNA typing results were converted to their serologic equivalents, especially for HLA-B alleles. For example, a “B*15:01/15:28/15:38, B*40:02/40:03” typing result was assigned as B*15 (62), B*40 (61). The assignment of serological equivalents was performed on the basis of the World Health Organization HLA nomenclature17 (link) and the international ImMunoGeneTics information system (IMGT)/HLA database (http://www.ebi.ac.uk/imgt/hla/).
+ Open protocol
+ Expand
8

Acquisition of Tumor and Normal Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Snap-frozen primary tumor tissues were obtained as part of institutional review board (IRB)-approved protocols at the Lineberger Comprehensive Cancer Center and the University of North Carolina. Samples from four prospective patients were collected under an ongoing clinical trial LCCC1108 (NCT01457196), whereas samples from 14 retrospective patients were collected under IRB#09-0989. For the four prospective patients, a matched normal tissue (whole blood), was also acquired. DNA was isolated with the Puregene DNA Purification Kit (Gentra Systems) or DNAeasy (QIAGEN).
+ Open protocol
+ Expand
9

Genotyping of SNPs in non-TNBC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA was extracted from peripheral venous blood (3–5 ml) of the individuals in the study group by using Gentra's PureGene DNA Purification kit (Gentra Systems, USA), Genotype data of SNPs were obtained by applying the DNA samples to the SEQUENOM MassARRAY platform (SEQUENOM MassARRAY, San Diego, CA). All samples of cases and controls were seeded randomly with non-template and CEPH controls in each plate for the iPLEX PCR array. The primers used in this study for genotyping were shown in Supplementary Table S1. All polymorphisms were genotyped successfully with genotyping call rate ranging from 95 to 100%. The genotyping experiment was carried out by the Bio-X Life Science Research Institute (Shanghai).
In the step two non-TNBC cases and controls study, PCR-based TaqMan assays (Applied Biosystems, Foster City, USA) of 652 non-TNBC patients and 890 controls were performed on a 7900 HT sequence detector system (Applied Biosystems) according to the manufacture's instructions. Genotyping was automatically attributed using the SDS2.4 software for allelic discrimination. 10% of the samples selected randomly were genotyped again and the reproducibility was 100%.
+ Open protocol
+ Expand
10

Quantitative PCR for Vector DNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Vector and 2-LTR circular DNA was detected using quantitative PCR assay based on a method previously described by Butler et al55 (link). Total cellular DNA was prepared using a Puregene DNA Purification Kit (Gentra Systems, Inc., Minneapolis, MN), from which a 250 ng or 500 ng sample was used for each reaction. To determine total, integrated, and 2-LTR circular vector DNA copy number, standard curves were generated by preparing serial dilutions of pcDNA-CS-CGW, genomic DNA from wild-type vector transduced HEK293 cells, or a 2-LTR circle reference plasmid that was generated upon the introduction of a 2-LTR fragment into a cloning vector, pCR4-TOPO (Invitrogen, Carlsbad, CA), respectively. Each sample was run in duplicate and data analysis was performed using Sequence Detection Systems 1.9.1 software (Applied Biosystems, Foster City, CA).
A 250 ng sample of total cellular DNA from transduced HEK293 cells at 3 days post-transduction was used for detection of 1-LTR circular vector DNA by standard PCR. 1-LTR circles were amplified using the following primers: 5’-GACCAATGACTTACAAGGCAGC-3’ (forward) and 5’-GCAAGCCGAGTCCTGCGTCG-3’ (reverse). The cycling conditions were 95°C for 10 min, thirty cycles of 92°C for 1 min, 56°C for 2 min, 72°C for 1.5 min, and 72°C for 7 min.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!